Alto Ingredients, Inc. (ALTO)

ALTO’s filings show a sharp rebound from prior-year losses, with continued profitability in the most recent quarter and a reasonable liquidity cushion (cash plus unused credit availability and covenant compliance). Valuation metrics are inexpensive (low trailing multiples and a high trailing free-cash-flow yield), but the business is fundamentally cyclical with a history of large earnings swings, a low Altman Z-Score, and an announced at-the-market share program that could be dilutive. Overall this looks more like a cyclical/value opportunity that needs close monitoring than a stable long-duration fundamental story.

No actionable short-term catalyst is in view — the only in-window first-party PR is a non-material H.C. Wainwright conference appearance and the Q2 beat (2026-08-05) is 40 days digested; media sentiment is determinate but essentially flat (baseline ≈ +0.04 → scoring ≈ +0.14, within the noise band), retail is unmeasured, and the Red-Flag Screen shows no severe or moderate flags, leaving an Absent setup.

Score 2 (mostly neutral / weak bearish, bounce-only): price $3.965 trades below SMA20 4.09, SMA50 4.61, SMA200 4.10 and EMA9 4.00 / EMA21 4.13 after a multi-month distribution from the ~$6 area; RSI 40.02 and Williams %R -75 show weak momentum; MACD remains below zero (-0.16 line vs -0.18 signal) with only a tentatively positive histogram (+0.02); ADX 38.15 marks strong directional movement, and with price under all averages and lower lows on the weekly frame that strength is downward. Two weeks of basing in the $3.88-4.16 range is stabilization, not reversal. Score and tradability are separate dimensions: even a stronger chart could not trade here because the qualitative override (qualitativeScore 2 < 3) hard-blocks any entry.